Mar 5 |
Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
|
Mar 4 |
Passage Bio files for $200M mixed shelf offering
|
Mar 4 |
Passage Bio GAAP EPS of -$1.86 beats by $0.04
|
Mar 4 |
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
|
Feb 27 |
Passage Bio to Participate in Upcoming Investor Conferences
|
Feb 12 |
We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully
|
Jan 31 |
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
|
Dec 20 |
Passage Bio stock climbs 9% on dementia study, program update
|
Dec 20 |
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
|
Nov 13 |
Passage Bio GAAP EPS of -$0.49 misses by $0.03
|